An otherwise healthy 15-year-old boy complains of an increasing number of bumps on his face over the last 3 years.
The Case
An otherwise healthy 15-year-old boy complains of an increasing number of little bumps on his face over the last 3 years. His mom has spent hundreds of dollars on ineffective over-the-counter and prescription acne products. What can an adolescent boy and his mother do?
Diagnosis: Angiofibroma
Clinically, angiofibromas are characterized by 2-mm to 4-mm, round, well-demarcated domed papules with a reddish-brown color that gradually increase in number and size. Although they can appear any time during childhood, they tend to blossom shortly before and during puberty. Although benign, they may become a nuisance because of bleeding and secondary infection after minor trauma.1 Histologic findings show a proliferation of fibroblasts and blood vessels, a fibrotic stroma with collagen, and occasionally a sparse inflammatory cell infiltrate of scattered lymphocytes.3
DIAGNOSIS
At initial presentation, angiofibromas may be mistaken for inflammatory acne papules. However, careful observation usually shows no evidence of inflammation, and open and closed comedones are also not present. Even when the correct diagnosis is made, a number of systemic conditions must be considered. The 2 genodermatoses most commonly associated with angiofibromas are TS and multiple endocrine neoplasia type 1 (MEN 1).2,4
Tuberous sclerosis is an autosomal dominant disorder associated with mutations in the TSC1 (9q34) or TSC2 (16p13) gene and characterized by multisystem hamartomas, including the development of cerebral cortical tubers that can lead to seizures and neurologic impairment.2
Multiple endocrine neoplasia 1 is associated with parathyroid, pituitary, and pancreatic endocrine tumors as well as some skin lesions.4 There are also isolated cases of facial angiofibromas in the context of Birt-Hogg-Dubé and neurofibromatosis.5
Diagnostic evaluation for TS includes careful physical examination of the patient and family members to look for shagreen plaques (collagenomas) and hypopigmented macules.5 When there is no evidence of TS, patients-especially those with a family history of MEN 1 or neuroendocrine tumors-should be considered for screening for MEN 1.4
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Worsening severity of AD in children associated with increased comorbidity onset risk
November 27th 2023Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort, investigators of a Sweden, nationwide, population-based cohort study found.
IDP-126 topical gel approved by FDA to treat acne in patients 12 years and up
October 21st 2023The topical gel is the first and only FDA-approved triple-combination, fixed-dose topical treatment for acne, and is set to be available in the first quarter of 2024, according to Bausch Health Companies Inc.
A 13-year-old girl with well-demarcated rash on back and chest
October 19th 2023A healthy 13-year-old girl presented with a 1-month history of an asymptomatic, well-demarcated rash on her back and upper chest. The eruption consisted of discrete, dark brown papules that coalesced into large, flat-topped plaques with mild superficial scale and accentuation of skin markings. What's the diagnosis?
Tapinarof cream 1% reduces itch as early as 24 hours after application for pediatric AD
October 13th 2023A rapid reduction in pruritis as early as 24 hours after first application was announced as new positive data from a pair of identical, phase 3 studies of tapinarof cream 1% in children as young as 2 years and adults with atopic dermatitis (AD).